NHS Framework Agreement for the Supply of Direct Oral Anticoagulant (DOAC) Medicines for the NHS in England
The NHS Commissioning Board (operating under the name of NHS England)contractFind a Tender ↗Ref ocds-h6vhtk-02cb5f32014L0024active
Estimated value
—
goods
Awarded value
—
Suppliers
3
Lots
1
3 awarded
Published
25 Nov 2021
Other contracts from The NHS Commissioning Board (operating under the name of NHS England)· 10
Most recent notices published by the same contracting authority.
Other contracts awarded to Bristol Myers Squibb· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| BH_NonClinical_Pharmacy_Car-T | contract | — | 26 Nov 2025 |
| Contract for POMALIDOMIDE (Imnovid) Capsules | contract | — | 28 Oct 2024 |
| Contract for POMALIDOMIDE (Imnovid) Capsules | contract | — | 30 Jan 2024 |
| Contract for POMALIDOMIDE (Imnovid) Capsules | contract | — | 30 Aug 2023 |
| NHS National Generic Pharmaceuticals Wave 14b | contract | — | 10 Aug 2023 |
| NHS National Generic Pharmaceuticals Wave 14b | contract | — | 10 Aug 2023 |
| NHS Framework for the North of England, Branded Medicine | call off | £7.7m | 08 Aug 2023 |
| NHS National Generic Pharmaceuticals Wave 14a | contract | £2.1m | 18 Jan 2023 |
| NHS National Generic Pharmaceuticals Wave 14a | contract | — | 18 Jan 2023 |
| NHS National Generic Pharmaceuticals - Lenalidomide | contract | — | 30 Sept 2022 |